Results 131 to 140 of about 79,111 (213)

Remote control of brain angiotensin II levels by angiotensin receptor blockers [PDF]

Hypertension Research, 2009
Masaki, Mogi, Masatsugu, Horiuchi
openaire   +2 more sources

Antihypertensive Effect of a Novel Angiotensin II Receptor Blocker Fluorophenyl Benzimidazole: Contribution of cGMP, Voltage-dependent Calcium Channels, and BK_Ca Channels to Vasorelaxant Mechanisms. [PDF]

Front Pharmacol, 2021
Iqbal H, Verma AK, Yadav P, Alam S, Shafiq M, Mishra D, Khan F, Hanif K, Negi AS, Chanda D.   +9 more
europepmc   +1 more source

Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding. [PDF]

J Hypertens, 2021
Cohen JB, D'Agostino McGowan L, Jensen ET, Rigdon J, South AM.   +4 more
europepmc   +1 more source

Drug-Induced Liver Injury Associated With the Angiotensin II Receptor Blocker Losartan in a 59-Year-Old Woman With Hypertension: A Case Report. [PDF]

Am J Case Rep
Al-Ajaj A, Melki W.
europepmc   +1 more source

Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy With Reference to Telmisartan and Cilnidipine. [PDF]

Cureus
Hiremath J, Kirpalani A, Chafekar D, Jayagopal PB, Ray S, Chopra VK, Dani S, Tripathi K, Sawhney JPS, Oomman A, Sathe S, Abdullakutty J, Kher V, Dewan D, Sharma K, Shete M, Vali PS, Jain S, Swami OC.   +18 more
europepmc   +1 more source

Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients. [PDF]

Eur Heart J Cardiovasc Pharmacother, 2020
Acanfora D, Ciccone MM, Scicchitano P, Acanfora C, Casucci G.   +4 more
europepmc   +1 more source

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox. [PDF]

Infect Control Hosp Epidemiol, 2021
Javanmard SH, Heshmat-Ghahdarijani K, Vaseghi G.   +2 more
europepmc   +1 more source

Postoperative angiotensin II receptor blocker use is associated with reduced 2-year reoperation rates in male patients undergoing arthroscopic rotator cuff repair. [PDF]

JSES Int
Fong S, Pettinelli NJ, Lee MS, Macleod JS, Gillinov SM, Monahan PF, Moran J, Jonnalagadda A, Mahatme RJ, Apostolakos JM, Jimenez AE.   +10 more
europepmc   +1 more source

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. [PDF]

Int J Mol Sci, 2020
Fujinaga Y, Kawaratani H, Kaya D, Tsuji Y, Ozutsumi T, Furukawa M, Kitagawa K, Sato S, Nishimura N, Sawada Y, Takaya H, Kaji K, Shimozato N, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H.   +17 more
europepmc   +1 more source

A Five-Year Prospective, Randomized, Open-Label Study of Standard-Dose Versus Low-Dose Prolonged-Release Tacrolimus With or Without Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Post Kidney Transplantation. [PDF]

Clin Transplant
Campbell PM, Cantarovich M, Gangji A, Houde I, Jevnikar AM, Monroy-Cuadros FM, Nickerson PW, Pâquet MR, Prasad GVR, Senécal L, Wolff JL, Schwartz JJ, Rush DN.   +12 more
europepmc   +1 more source